Financials

  • Market Capitalization 138.12 M
  • Employee 34
  • Founded 2004
  • CEO Christopher U. Missling Ph.D.
  • Website www.anavex.com
  • Headquarter New York, United States
  • FIGI BBG000C9K8K4
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-16.48
Fiyat/satışlar oranı
174.66

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
3686
CDXS
Codexis, Inc. - Common Stock
1.32 USD-6.38%-2.94%-8.97%-46.56%144.55 M USD
3689
NBP
NovaBridge Biosciences - American Depositary Shares
1.30 USD-1.52%-7.14%-18.24%-71.18%150.00 M USD
3710
OTLK
Outlook Therapeutics, Inc. - Common Stock
0.57 USD-3.39%0.00%-12.31%+38.18%138.77 M USD
3716
IPHA
Innate Pharma S.A. - American Depositary Shares
1.46 USD-1.35%-8.18%-21.51%-32.41%136.83 M USD

Haberler